Clinical Data
Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter.
A Focus on Clinical Research
HDx
Retention of beneficial molecules and coagulation factors during haemodialysis and haemodiafiltration - Voigt M et al.
View resource
HDx
The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease - Alves FC, et al.
View resource
HDx
The Place of Large Pore Membranes in the Treatment Portfolio of Patients on Hemodialysis - Van Biesen W et al.
View resource
HDx
In Vitro Cytokine Removal: Comparison of Conventional High-Flux Dialyzers and Middle-Cut-Off Dialyzer (Theranova HDx)
View resource
HDx
Removal of Middle Molecules Using Medium Cut-Off Membranes in Hemodialysis Mode vs. High-Flux Membranes in Post-Dilutional Online Hemodiafiltration Mode: The REMOC Study
View resource
HDx
Removal of Middle Molecules Using Medium Cut-Off Membranes in Hemodialysis Mode vs. High-Flux Membranes in Post-Dilutional Online Hemodiafiltration Mode: The REMOC Study
View resource
HDx
The Comparison of Vancomycin Removal Between Medium Cut-Off(Theranova®) and Other Dialyzers
View resource
HDx
Effects of a medium cut-off (Theranova®) dialyser on haemodialysis patients: a prospective, cross-over study
View resource
HDx